Of note, aspartic acid can be converted into asparagine by asparagine synthetase (ASNS), and reduction of asparagine by knockdown of ASNS or treatment with bacterial l-asparaginase reduces breast cancer invasion, circulating tumor cells (CTC), and metastasis without affecting primary tumor growth (Knott et al., 2018). The gene discussed is ASNS; the disease is neoplasm.